|
Normal
|
Disease state |
|
|
None
|
Compound treatment |
|
|
Monocyte
|
Cell type |
|
|
Blood
|
Organism part |
|
|
Bone marrow
|
Organism part |
|
|
Peripheral blood
|
Organism part |
|
|
Epithelial cell
|
Cell type |
|
|
Pan troglodytes
|
Organism |
|
|
Homo sapiens
|
Organism |
|
|
Stromal cell
|
Cell type |
|
|
Caudate nucleus
|
Organism part |
|
|
FLAP
|
Compound treatment |
|
|
MK886
|
Compound treatment |
|
|
Macaca mulatta
|
Organism |
|
|
HNRPA2B
|
Compound treatment |
|
|
Invasive ductal carcinoma
|
Histology |
|
|
N/a
|
Test result |
|
|
Glioblastoma
|
Disease state |
|
|
0 cm away from the tumor bound...
|
Observation |
|
|
Estrogen receptor 1 positive; ...
|
Test result |
|
|
Hydroxyurea
|
Compound treatment |
|
|
Liver
|
Organism part |
|
|
Caco-2
|
Cell line |
|
|
BT-474
|
Cell line |
|
|
Breast carcinoma
|
Disease state |
|
|
Not applicable
|
Histology |
|
|
Tonsil
|
Organism part |
|
|
Nocodazole
|
Compound treatment |
|
|
MCF-7
|
Cell line |
|
|
Estrogen receptor 1 positive; ...
|
Test result |
|
|
HL-60
|
Cell line |
|
|
ERalpha transfected
|
Genotype |
|
|
Primary
|
Disease staging |
|
|
Normal
|
Histology |
|
|
Estrogen receptor 1 positive; ...
|
Test result |
|
|
Control
|
Compound treatment |
|
|
Skeletal muscle
|
Organism part |
|
|
Uninfected
|
Infection |
|
|
Gastric cancer
|
Disease state |
|
|
MDA-MB-231
|
Cell line |
|
|
Heat-killed HL60 cell lysate
|
Infection |
|
|
Circulating neutrophil
|
Cell type |
|
|
Alveolar space neutrophil
|
Cell type |
|
|
Glucocorticoid sensitive
|
Phenotype |
|
|
Pretreatment primary sample
|
Clinical info |
|
|
Lymphatic endothelial cell
|
Cell type |
|
|
Glucocorticoid resistant
|
Phenotype |
|
|
SW480
|
Cell line |
|
|
SW620
|
Cell line |
|
|
Dimethyl sulfoxide
|
Compound treatment |
|
|
CodeLink Labeling
|
Protocol type |
|
|
BT474
|
Cell line |
|
|
SKBR3
|
Cell line |
|
|
Fetal bovine serum in media
|
Growth condition |
|
|
T47D
|
Cell line |
|
|
Enzo Labeling
|
Protocol type |
|
|
Affymetrix Labeling
|
Protocol type |
|
|
Heat-killed Anaplasma phagocyt...
|
Infection |
|
|
MDA468
|
Cell line |
|
|
Heregulin
|
Compound treatment |
|
|
Kaposi's sarcoma-associated he...
|
Infection |
|
|
Grade II
|
Tumor grading |
|
|
Inter-prandial lipid micelles ...
|
Growth condition |
|
|
ITS medium
|
Growth condition |
|
|
Postprandial lipid micelles in...
|
Growth condition |
|
|
ITS medium with albumin-bound ...
|
Growth condition |
|
|
Rapamycin
|
Compound treatment |
|
|
Methotrexate
|
Compound treatment |
|
|
Oligodendroglioma
|
Disease state |
|
|
Neutrophil
|
Cell type |
|
|
Acute radiation toxicity
|
Clinical history |
|
|
Endometrioid carcinoma
|
Disease state |
|
|
Grade IV
|
Tumor grading |
|
|
Cadmium chloride 2.5-hydrate
|
Compound treatment |
|
|
CD3+ CD4+ CD8- CD45RA+ CD62L+
|
Phenotype |
|
|
Naive T cell
|
Cell type |
|
|
Malignant melanoma
|
Disease state |
|
|
10 ng/ml LPS in media
|
Growth condition |
|
|
Media only
|
Growth condition |
|
|
Teratozoospermia
|
Disease state |
|
|
Normospermic
|
Disease state |
|
|
Serum starvation + thymidine b...
|
Growth condition |
|
|
None
|
Infection |
|
|
Epidermal keratinocyte
|
Cell type |
|
|
SkinEthic keratinocyte
|
Cell type |
|
|
Bacterial endotoxin
|
Compound treatment |
|
|
Umbilical cord
|
Organism part |
|
|
Fetus
|
Developmental stage |
|
|
Adult
|
Developmental stage |
|
|
Frontal cortex, superior motor...
|
Organism part |
|
|
Stage I
|
Disease staging |
|
|
Synovial fluid
|
Organism part |
|
|
HPL1
|
Cell line |
|
|
Baseline uninfected
|
Disease state |
|
|
Fetal liver
|
Organism part |
|
|
Infrared light
|
Light |
|
|
Spermatocyte
|
Cell type |
|
|
Vascular smooth muscle cell
|
Cell type |
|
|
Lipopolysaccharide
|
Compound treatment |
|
|
CD71+ early erythroid
|
Cell type |
|
|
Inferior parietal lobule
|
Organism part |
|
|
Jurkat
|
Cell line |
|
|
Stage II
|
Disease staging |
|
|
Organism_part
|
Material type |
|
|
Cell
|
Material type |
|
|
T47-D
|
Cell line |
|
|
Chondrocyte
|
Cell type |
|
|
Placenta
|
Organism part |
|
|
Kidney
|
Organism part |
|
|
Johnsen score count 2: Sertoli...
|
Histology |
|
|
Fibroblast
|
Cell type |
|
|
Metastatic
|
Disease staging |
|
|
Training set
|
Population |
|
|
Test set
|
Population |
|
|
Anaplasma phagocytophilum
|
Infection |
|
|
Serum starvation synchronizati...
|
Growth condition |
|
|
Interferon-gamma + lipopolysac...
|
Compound treatment |
|
|
M1 macrophage
|
Cell type |
|
|
Ultraviolet light
|
Light |
|
|
Mannitol
|
Compound treatment |
|
|
Benign nevi
|
Disease state |
|
|
KSHV latent infection
|
Disease state |
|
|
4OH-tamoxifen
|
Compound treatment |
|
|
CD34+
|
Cell type |
|
|
Lymph node
|
Organism part |
|
|
MCF10A
|
Cell line |
|
|
Stimulated polymorphonuclear l...
|
Cell type |
|
|
Unstimulated polymorphonuclear...
|
Cell type |
|
|
HL60 cell lysate
|
Infection |
|
|
Normal
|
Clinical history |
|
|
Hypericin incubated, not irrad...
|
Growth condition |
|
|
Hypericin incubated, irradiate...
|
Growth condition |
|
|
HTERT/HPVE6/HPVE7/SV40t transf...
|
Gene modification |
|
|
TIVE
|
Cell line |
|
|
5-aza-2'-deoxycytidine + trich...
|
Compound treatment |
|
|
GLI72
|
Cell line |
|
|
Appendix
|
Organism part |
|
|
Huntington's disease
|
Disease state |
|
|
Trichostatin A
|
Compound treatment |
|
|
TaN0M0
|
Disease staging |
|
|
HTERT/HPVE6 transfection
|
Gene modification |
|
|
Acute malaria, natural infecti...
|
Disease state |
|
|
Endothelial cell + pericyte
|
Cell type |
|
|
Relapse 0; ER status ER+; brai...
|
Clinical info |
|
|
Testis
|
Organism part |
|
|
Atrial mycocardium
|
Organism part |
|
|
Ventricular myocardium
|
Organism part |
|
|
SKMEL5
|
Cell line |
|
|
HTERT/HPVE6/HPVE7/SV40t/hRas t...
|
Gene modification |
|
|
Ischemic cardiomyopathy
|
Disease state |
|
|
Astrocyte
|
Cell type |
|
|
HeLa
|
Cell line |
|
|
White blood cell
|
Cell type |
|
|
Platelet
|
Cell type |
|
|
CD3- CD4+ CD8-
|
Phenotype |
|
|
Intrathymic T progenitor cell
|
Cell type |
|
|
MiR15a/miR16-1 transfection
|
Gene modification |
|
|
Ciliary ganglion
|
Organism part |
|
|
Burkitt's lymphoma
|
Disease state |
|
|
Dermal fibroblast
|
Cell type |
|
|
PC3
|
Cell line |
|
|
ERbeta transfected
|
Genotype |
|
|
G3
|
Tumor grading |
|
|
SNU1
|
Cell line |
|
|
Stage IV/3
|
Disease staging |
|
|
T3bN1M0
|
Disease staging |
|
|
G1
|
Tumor grading |
|
|
Primary gastric tumor
|
Organism part |
|
|
Normal
|
Disease staging |
|
|
Head and neck squamous cell ca...
|
Disease state |
|
|
AIDS-KS, HIV+, nodular (late) ...
|
Disease state |
|
|
Actinomycin D
|
Compound treatment |
|
|
Duodenum
|
Organism part |
|
|
CD4+ T cell
|
Cell type |
|
|
T4aN0M0
|
Disease staging |
|
|
Pseudomonas aeruginosa
|
Infection |
|
|
Erythrocyte
|
Cell type |
|
|
Kaposi's sarcoma
|
Disease state |
|
|
Plasma cell
|
Cell type |
|
|
B lymphocyte
|
Cell type |
|
|
Skin substitute
|
Cell type |
|
|
Macrophage
|
Cell type |
|
|
ITV
|
Cell line |
|
|
Frontal cortex, primary motor ...
|
Organism part |
|
|
Seminiferous tubule
|
Organism part |
|
|
Waldenstrom's macroglobulinemi...
|
Disease state |
|
|
Term
|
Developmental stage |
|
|
Midgestation
|
Developmental stage |
|
|
Staphylococcus aureus
|
Infection |
|
|
BCKN-1
|
Cell line |
|
|
GLI60
|
Cell line |
|
|
T4aN2M1
|
Disease staging |
|
|
BJAB
|
Cell line |
|
|
Pancreatic cancer
|
Disease state |
|
|
Obesity
|
Disease state |
|
|
Tumor
|
Organism part |
|
|
Effector memory CD4 T cell
|
Target cell type |
|
|
Cartilage
|
Organism part |
|
|
Control for EGF
|
Compound treatment |
|
|
CD4+ T-cell
|
Cell type |
|
|
Nickel(II) chloride hexahydrat...
|
Compound treatment |
|
|
Symptomatic
|
Disease staging |
|
|
Empty vector
|
Gene modification |
|
|
Total_RNA
|
Material type |
|
|
Polysome-associated RNA
|
Material type |
|
|
Diagnosed with skin cancer bef...
|
Clinical history |
|
|
Johnsen score count 10: full s...
|
Histology |
|
|
Relapse 1; ER status ER+; brai...
|
Clinical info |
|
|
CXCR5(hi)ICOS(hi) CD4 T cell
|
Target cell type |
|
|
Lung adenocarcinoma
|
Disease state |
|
|
Chronic lymphocytic leukemia
|
Disease state |
|
|
Female
|
Sex |
|
|
Male
|
Sex |
|
|
Cerebellum
|
Organism part |
|
|
Dendritic cell-derived osteocl...
|
Cell type |
|
|
Johnsen score count 3.2: Serto...
|
Histology |
|
|
Respiratory syncytial virus
|
Infection |
|
|
BC-1
|
Cell line |
|
|
Uninfected control
|
RNAi |
|
|
Whole blood
|
Organism part |
|
|
Ethanol
|
Vehicle |
|
|
Estrogen receptor 1 positive; ...
|
Test result |
|
|
T84
|
Cell line |
|
|
Cystic change
|
Histology |
|
|
IMP(1,3)A
|
RNAi |
|
|
Breast cancer
|
Disease state |
|
|
Multiple myeloma
|
Disease state |
|
|
ITM-E6E7-ST
|
Cell line |
|
|
Non-steroidal anti-inflammator...
|
Compound treatment |
|
|
No induction
|
Protocol type |
|
|
Sapphyrin PCI-2054
|
Compound treatment |
|
|
IL-22
|
Compound treatment |
|
|
GLI56
|
Cell line |
|
|
Vasectomized
|
Clinical history |
|
|
Chronic myelogenous leukemia
|
Disease state |
|
|
SsMCF7
|
Cell line |
|
|
Dendritic cell
|
Cell type |
|
|
None
|
Gene modification |
|
|
Cigarette smoke
|
Compound treatment |
|
|
HaCaT
|
Cell line |
|
|
Naive CD4 T cell
|
Target cell type |
|
|
Leishmania donovani
|
Infection |
|
|
U87
|
Cell line |
|
|
U373
|
Cell line |
|
|
Refractory anemia with ringed ...
|
Clinical info |
|
|
Cornea epithelium
|
Organism part |
|
|
Conjunctival epithelium
|
Organism part |
|
|
Gorilla gorilla
|
Organism |
|
|
Idiopathic dilated cardiomyopa...
|
Disease state |
|
|
Pan paniscus
|
Organism |
|
|
Control
|
Phenotype |
|
|
ERalpha L540Q transfected
|
Genotype |
|
|
Duchenne muscular dystrophy
|
Disease state |
|
|
MDS-associated acute myeloid l...
|
Disease state |
|
|
Acute myeloid leukemia
|
Disease state |
|
|
Plasmacytoid dendritic cell
|
Cell type |
|
|
Classic-KS, HIV-, nodular (lat...
|
Disease state |
|
|
Acute promyelocytic leukemia
|
Disease state |
|
|
Collagen/chondroitin tissue en...
|
Growth condition |
|
|
Tissue culture polystyrene dis...
|
Growth condition |
|
|
T4bN1M0
|
Disease staging |
|
|
Intraepithelium
|
Organism part |
|
|
Native skin
|
Cell type |
|
|
Benign
|
Disease staging |
|
|
Acute lymphocytic leukemia
|
Disease state |
|
|
Polyarticular rheumatoid arthr...
|
Disease state |
|
|
CD11c+ dendritic cell
|
Cell type |
|
|
Colorectal cancer recurrence
|
Disease state |
|
|
Colorectal cancer recurrence-f...
|
Disease state |
|
|
AdERb high moi
|
Gene modification |
|
|
T cell
|
Cell type |
|
|
Peripheral blood mononuclear c...
|
Cell type |
|
|
Normal donor
|
Clinical info |
|
|
Growth medium
|
Vehicle |
|
|
Beas2B
|
Cell line |
|
|
T2N0M0
|
Disease staging |
|
|
Acute rejection
|
Clinical info |
|
|
Measles virus Chicago-1 strain
|
Infection |
|
|
Psoriatic lesional biopsy
|
Clinical info |
|
|
Uninvolved biopsy
|
Clinical info |
|
|
CD8+ T cell
|
Cell type |
|
|
Spleen
|
Organism part |
|
|
Central memory 1 CD4 T cell
|
Target cell type |
|
|
Met5A
|
Cell line |
|
|
Senescence bypassed
|
Phenotype |
|
|
PDGF-A dominant-negative
|
Genotype |
|
|
Epilepsy
|
Disease state |
|
|
Astrocytic tumor
|
Disease state |
|
|
Refractory anemia with excess ...
|
Clinical info |
|
|
Monocyte-derived osteoclast
|
Cell type |
|
|
Sapphyrin PCI-2050
|
Compound treatment |
|
|
Adenocarcinoma
|
Disease state |
|
|
Geriatric
|
Developmental stage |
|
|
Pediatric
|
Developmental stage |
|